Publications
-
Pérez-Torres Lobato M, Navarro L, de Noriega I, Morey Olivé M, Solano-Páez P, Rubio Pérez E, Garrido Colino C, García Abos M, Tallón García M, Huidobro Labarga B, Portugal Rodríguez R, López Ibor B, Lassaletta Á, Morgenstern Isaak A, Cruz-Martínez O, Valero Arrese L, Llort Sales A, Gros Subias L, Márquez Vega C, Moreno L and Quiroga-Cantero E.
Palliative care for children with central nervous system tumors: results of a Spanish multicenter study
CLINICAL & TRANSLATIONAL ONCOLOGY . 26(3): 786-795.
-
Challinor J, Davidson A, Chantada G, Kebudi R and Pritchard-Jones K.
The role of International Society of Paediatric Oncology (SIOP) in advancing global childhood cancer care
ecancermedicalscience . 18: 1678-1678.
-
Chantada L, Gorostegui M, Lowe J, Ranasinghe N, Villegas L, Geel J, Howard S, Bouffet E, Chantada G, Challinor J and Cappellano A.
SIOP pediatric oncology services Global Mapping Program: Latin American data collection
PEDIATRIC BLOOD & CANCER . 71(2): . Number of citations: 2
-
van Tilburg CM, Kilburn LB, Perreault S, Schmidt R, Azizi AA, Cruz-Martínez O, Zápotocký M, Scheinemann K, Meeteren AYNS, Sehested A, Opocher E, Driever PH, Avula S, Ziegler DS, Capper D, Koch A, Sahm F, Qiu J, Tsao LP, Blackman SC, Manley P, Milde T, Witt R, Jones DTW, Hargrave D and Witt O.
LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration
BMC Cancer . 24(1): 147-147. Number of citations: 16
-
Brown, Elizabeth J., Balaguer-Lluna, Leire, Cribbs, Adam P., Philpott, Martin, Campo, Leticia, Browne, Molly, Wong, Jong Fu, Oppermann, Udo, Carcaboso AM, Bullock, Alex N. and Farnie, Gillian.
PRMT5 inhibition shows in vitro efficacy against H3K27M-altered diffuse midline glioma, but does not extend survival in vivo
SCIENTIFIC REPORTS . 14(1): . Number of citations: 2
-
Cancela MB, Dinardi M, Aschero MR, Zugbi S, Chantada G, Baroni L and Schaiquevich P.
The importance of basic and translational research in caring for children with malignant solid tumors in Latin America
REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH . 48: .
-
Wiese M, Pohlmeier B, Kubiak K, El-Khouly FE, Sitte M, Carcaboso AM, Baugh JN, Perwein T, Nussbaumer G, Karremann M, Gielen GH, Salinas G and Kramm CM.
Boswellic acid formulations are not suitable for treatment of pediatric high-grade glioma due to tumor promoting potential
Journal of Traditional and Complementary Medicine . 14(1): 101-108.
-
Aschero MR, Ganiewich D, Lamas G, Restrepo-Perdomo CA, Ottaviani D, Zugbi S, Camarero S, Néspoli E, Cuadrado-Vilanova M, Pérez-Jaume S, Pascual-Pastó G, Sampor C, Grigorovski N, Salas B, Suñol M, Carcaboso AM, Mora J, de Dávila MTG, Doz F, Radvanyi F, Abramson DH, Llera AS, Schaiquevich PS, Lubieniecki F and Chantada G.
Immunohistochemical expression of TFF1 is a marker of poor prognosis in retinoblastoma
PEDIATRIC BLOOD & CANCER . 71(1): . Number of citations: 1
-
Simao-Rafael M, Cruz-Martínez O, Pérez-Jaume S, Santa-María López V, Lavarino C, Salvador-Hernandez H, Muchart-Lopez J, Hinojosa J, Suñol M and Morales-La Madrid A.
Use of bevacizumab in pediatric low-grade glioma: Ten-year experience in a single center
EJC Paediatric Oncology . 2: 100115.
-
Zugbi S, Aschero R, Ganiewich D, Cancela MB, Winter U, Ottaviani D, Sampor C, Dinardi M, Torbidoni AV, Mena M, Balaguer-Lluna L, Lamas G, Sgroi M, Lagomarsino E, Lubieniecki F, Fandiño A, Radvanyi F, Abramson DH, Podhajcer O, Llera AS, Cafferata EG, Chantada G, Carcaboso AM and Schaiquevich P.
Establishment and Comprehensive Characterization of a Novel Preclinical Platform of Metastatic Retinoblastoma for Therapeutic Developments
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE . 64(15): 27-27. Number of citations: 2